SoftOx Solutions AS (SOFTX) - Total Liabilities
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) has total liabilities worth Nkr10.98 Million NOK (≈ $1.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how many days can SoftOx Solutions AS fund operations to measure how many days the company can operate on defensive assets alone.
SoftOx Solutions AS - Total Liabilities Trend (2016–2025)
This chart illustrates how SoftOx Solutions AS's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of SoftOx Solutions AS to evaluate the company's liquid asset resilience ratio.
SoftOx Solutions AS Competitors by Total Liabilities
The table below lists competitors of SoftOx Solutions AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
True North Copper Ltd
AU:TNC
|
Australia | AU$23.71 Million |
|
DocGo Inc
NASDAQ:DCGO
|
USA | $98.02 Million |
|
Haverty Furniture Companies Inc
NYSE:HVT-A
|
USA | $345.68 Million |
|
Kristal Kola ve Mesrubat Sanayi Ticaret AS
IS:KRSTL
|
Turkey | TL1.03 Billion |
|
Imas Makina Sanayi AS
IS:IMASM
|
Turkey | TL1.62 Billion |
|
Tactical Resources Corp. Common Shares
NASDAQ:TREO
|
USA | $9.29 Million |
|
Ditas Dogan Yedek Parca Imalat ve Teknik AS
IS:DITAS
|
Turkey | TL2.35 Billion |
|
Samwha Elec
KO:011230
|
Korea | ₩56.82 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down SoftOx Solutions AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SoftOx Solutions AS (SOFTX) total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SoftOx Solutions AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SoftOx Solutions AS (2016–2025)
The table below shows the annual total liabilities of SoftOx Solutions AS from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr10.98 Million ≈ $1.16 Million |
-57.71% |
| 2024-12-31 | Nkr25.96 Million ≈ $2.73 Million |
-72.64% |
| 2023-12-31 | Nkr94.87 Million ≈ $9.98 Million |
+53.45% |
| 2022-12-31 | Nkr61.83 Million ≈ $6.51 Million |
+237.34% |
| 2021-12-31 | Nkr18.33 Million ≈ $1.93 Million |
+65.23% |
| 2020-12-31 | Nkr11.09 Million ≈ $1.17 Million |
-40.03% |
| 2019-12-31 | Nkr18.50 Million ≈ $1.95 Million |
+105.86% |
| 2018-12-31 | Nkr8.98 Million ≈ $945.45K |
+114.38% |
| 2017-12-31 | Nkr4.19 Million ≈ $441.01K |
-34.30% |
| 2016-12-31 | Nkr6.38 Million ≈ $671.23K |
-- |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx So… Read more